Skip to content

Melatonin

Melatonin is a hormone primarily released by the pineal gland that regulates sleep-wake cycles. It is commonly used as a supplement to improve sleep quality and manage circadian rhythm disorders. Its role in longevity and health optimization is linked to its antioxidant properties and potential to enhance sleep, which is crucial for overall health and recovery.

Intelligence Profile

Research Papers

A range of studies and clinical trials have explored the effects and applications of melatonin, offering insights into its potential benefits and mechanisms.

One randomized controlled trial published in Midwifery investigated the effect of kangaroo care on melatonin levels in maternal breast milk, alongside other outcomes such as growth and physiological stability in premature infants. This trial highlights the role of maternal behaviors in modulating melatonin for infant development.

In a systematic review published in Physiological Reports, melatonin is examined as a protective agent against endocrine disruption across various tissues. This review suggests that melatonin may have widespread biological effects beyond its well-known role in sleep regulation.

Research in the Journal of Pineal Research explored melatonin's inhibition of osteoclastogenesis, the process that leads to bone resorption, by interfering with specific intracellular pathways. Another study in the same journal looked at melatonin's impact on soybean growth, implying potential agricultural applications.

While examining plant responses, a study illustrated how melatonin signaling could alleviate iron starvation in rice by affecting iron mobilization and transport, showing its broader biological significance.

Clinical trial activity includes NCT05084196, a Phase 3 study on melatonin's potential to prevent kidney injury, currently recruiting participants. This suggests interest in melatonin's use in renal health. Another ongoing trial (NCT05474846) assesses melatonin in combination therapies for sleep disturbances in cancer patients, indicating its potential in supportive cancer care.

It should be noted that a trial assessing melatonin for COVID-19 (NCT04784754) was withdrawn, highlighting the complexities and challenges of clinical research in evolving disease contexts.

The evidence emphasizes melatonin's multifaceted role in health, although further investigation is required to substantiate and expand upon these findings.

Disclaimer: This information is for educational purposes and not intended as medical advice. Always consult healthcare professionals for medical concerns.

Free account required

Research papers requires a free AXIFI account to access clinical data, safety profiles, and research papers.